Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
72.50    4.05 (5.92%)
Bid:
72.70
Ask:
72.90
Spread: 0.20 (0.275%)
Market Cap: £269.09m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Director/PDMR Shareholding

20 Feb 2023 10:00

RNS Number : 4402Q
RWS Holdings PLC
20 February 2023
 

 

For immediate release 20 February 2023

 

RWS Holdings plc

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 

Grant of options under the 2023 Save as you Earn (SAYE) scheme

 

RWS Holdings plc ("RWS" or "the Group"), a unique world-leading provider of technology-enabled language, content and intellectual property services, announces that on 16 February 2023 the following persons discharging managerial responsibilities of the Group were granted options over ordinary shares of 1 pence each under the Group's SAYE scheme.

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Candida Davies

2. Daniel Bennett

3. Terry Doyle

4. Jane Hyde

5. Christopher Lewey

2.

Reason for the notification

a.

Position/status

1. Chief Financial Officer

2. President, IP Services

3. Chief Information Officer

4. General Counsel and Company Secretary

5. Group Corporate Development Director

b.

Initial notification/Amendment

Initial Announcement

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

RWS Holdings plc

b.

LEI

213800YGBGTTSKUVK111

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the Financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

 

GB00BVFCZV34

b.

Nature of the transaction

Grant of options under the 2023 SAYE scheme with an exercise price of 361p per share

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

1. 4,986

2. 4,986

3. 4,986

4. 4,986

5. 4,986

d.

Aggregated information

· Aggregated volume

· Price

 

24,930

e.

Date of the transaction

16 February 2023

f.

Place of the transaction

Outside a trading venue

 

 

In total, 287,292 share options were granted under the Group's SAYE scheme, which in normal circumstances will not be exercisable until the completion of a three-year savings period ending on 1 April 2026 and will be exercisable for a period of six months thereafter.

 

For further information, please contact:

 

RWS Holdings plc

Andrew Brode, Chairman

Ian El-Mokadem, Chief Executive Officer

Candida Davies, Chief Financial Officer

 

 

 

01753 480200

 

MHP (Financial PR advisor)

Katie Hunt / Simon Hockridge

 

rws@mhpgroup.com

020 3128 8100

 

Numis (Nomad & Joint Broker)

Stuart Skinner / Kevin Cruickshank / Will Baunton

 

 

 

020 7260 1000

 

Berenberg (Joint Broker)

Ben Wright / Toby Flaux / Alix Mecklenburg-Solodkoff

 

020 3207 7800

 

 

 

About RWS:

RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our unique combination of technology and cultural expertise helps our clients to grow by ensuring they are understood anywhere, in any language.

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

 

We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.

 

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).

 

For further information, please visit: www.rws.com

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKKBPCBKKDBB
Date   Source Headline
24th Jul 20237:00 amRNSTransaction in Own Shares
21st Jul 20237:00 amRNSTransaction in Own Shares
20th Jul 20237:00 amRNSTransaction in Own Shares
19th Jul 20237:00 amRNSTransaction in Own Shares
18th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20239:30 amRNSAcquisition
12th Jul 20237:00 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTransaction in Own Shares
10th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
6th Jul 20237:00 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSTransaction in Own Shares
4th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20234:15 pmRNSTotal Voting Rights
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSTransaction in Own Shares
29th Jun 20237:00 amRNSTransaction in Own Shares
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20237:00 amRNSTransaction in Own Shares
23rd Jun 20237:00 amRNSTransaction in Own Shares
22nd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares
20th Jun 20237:00 amRNSTransaction in Own Shares
19th Jun 20237:00 amRNSTransaction in Own Shares
16th Jun 202311:15 amRNSTransaction in Own Shares - Replacement
16th Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 20237:00 amRNSTransaction in Own Shares
14th Jun 20237:00 amRNSShare Repurchase Programme
12th Jun 20233:45 pmRNSDirector/PDMR Shareholding
8th Jun 20237:00 amRNSHalf-year Report
15th May 20233:10 pmRNSHolding(s) in Company
3rd May 20237:00 amRNSDirector/PDMR Shareholding
2nd May 202311:45 amRNSDirector/PDMR Shareholding
27th Apr 20235:13 pmRNSHolding(s) in Company
27th Apr 20233:25 pmRNSDirector/PDMR Shareholding
26th Apr 20237:00 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSHalf Year Trading Statement
20th Apr 202310:15 amRNSCyber Incident
13th Mar 20237:00 amRNSUpdate on Silicon Valley Bank
22nd Feb 20234:30 pmRNSResult of AGM
22nd Feb 20237:00 amRNSAGM Statement
20th Feb 202310:00 amRNSDirector/PDMR Shareholding
10th Feb 202311:00 amRNSOption exercise and increase in share capital
27th Jan 20237:00 amRNSPosting of Annual Report and Notice of AGM
25th Jan 20237:00 amRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSOption exercise and increase in share capital
5th Jan 202310:30 amRNSOption exercise and increase in share capital
3rd Jan 202310:00 amRNSDirectorate Change
15th Dec 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.